DPY19L1

gene
On this page

Also known as KIAA0877

Summary

DPY19L1 (dpy-19 like C-mannosyltransferase 1, HGNC:22205) is a protein-coding gene on chromosome 7p14.2, encoding Protein C-mannosyl-transferase DPY19L1 (Q2PZI1). C-mannosyltransferase that mediates the C-mannosylation tryptophan residues on target proteins.

Predicted to enable mannosyltransferase activity. Predicted to be involved in protein glycosylation. Located in membrane.

Source: NCBI Gene 23333 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 106 total — 1 likely-pathogenic
  • MANE Select transcript: NM_001366673

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22205
Approved symbolDPY19L1
Namedpy-19 like C-mannosyltransferase 1
Location7p14.2
Locus typegene with protein product
StatusApproved
AliasesKIAA0877
Ensembl geneENSG00000173852
Ensembl biotypeprotein_coding
OMIM613892
Entrez23333

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 14 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay

ENST00000310974, ENST00000428054, ENST00000446375, ENST00000462134, ENST00000463538, ENST00000481923, ENST00000493989, ENST00000612226, ENST00000638088, ENST00000685246, ENST00000687726, ENST00000688296, ENST00000690503, ENST00000690666, ENST00000928159, ENST00000928160, ENST00000944845, ENST00000944846, ENST00000944847, ENST00000944848, ENST00000944849

RefSeq mRNA: 2 — MANE Select: NM_001366673 NM_001366673, NM_015283

CCDS: CCDS43567, CCDS94084

Canonical transcript exons

ENST00000638088 — 22 exons

ExonStartEnd
ENSE000015053743494015334940327
ENSE000015954543495798434958070
ENSE000016047243494979734949898
ENSE000016370403494566734945716
ENSE000016709003493799434938119
ENSE000016735213493927634939375
ENSE000016965543495469834954778
ENSE000017386983494176534941884
ENSE000017635243494261534942639
ENSE000017866483494763034947701
ENSE000034996553495530834955367
ENSE000035442593498988434989941
ENSE000035520363501133035011450
ENSE000035710413496943334969532
ENSE000035766163501857235018596
ENSE000035794413501046835010561
ENSE000036318443501788235017969
ENSE000036567373497351434973605
ENSE000036905133496689434966971
ENSE000036907753501356835013705
ENSE000037961883503709735037485
ENSE000039002683492888134931729

Expression profiles

Bgee: expression breadth ubiquitous, 286 present calls, max score 96.56.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 29.5912 / max 244.9347, expressed in 1805 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
8353128.04861805
835290.6909364
835300.6162350
835320.122442
835330.113124

Top tissues by expression

298 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ganglionic eminenceUBERON:000402396.56gold quality
ponsUBERON:000098895.03gold quality
stromal cell of endometriumCL:000225593.60gold quality
right testisUBERON:000453493.58gold quality
left testisUBERON:000453393.54gold quality
spinal cordUBERON:000224092.59gold quality
C1 segment of cervical spinal cordUBERON:000646992.57gold quality
ventricular zoneUBERON:000305392.44gold quality
spermCL:000001992.27gold quality
testisUBERON:000047392.18gold quality
choroid plexus epitheliumUBERON:000391191.85gold quality
inferior vagus X ganglionUBERON:000536390.96gold quality
male germ cellCL:000001590.73gold quality
medulla oblongataUBERON:000189690.62gold quality
embryoUBERON:000092290.30gold quality
inferior olivary complexUBERON:000212790.26gold quality
germinal epithelium of ovaryUBERON:000130490.19gold quality
subthalamic nucleusUBERON:000190690.19gold quality
cerebellar vermisUBERON:000472089.61gold quality
superior vestibular nucleusUBERON:000722789.56gold quality
corpus callosumUBERON:000233689.43gold quality
adrenal tissueUBERON:001830389.28gold quality
prefrontal cortexUBERON:000045189.00gold quality
cartilage tissueUBERON:000241888.61gold quality
endometriumUBERON:000129588.43gold quality
Brodmann (1909) area 10UBERON:001354188.40gold quality
smooth muscle tissueUBERON:000113588.28gold quality
calcaneal tendonUBERON:000370187.92gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.84gold quality
dorsolateral prefrontal cortexUBERON:000983487.84gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.72

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): NR1I2

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriodpy19l1lENSDARG00000069995
mus_musculusDpy19l1ENSMUSG00000043067
rattus_norvegicusDpy19l1ENSRNOG00000026589
caenorhabditis_elegansWBGENE00001078

Paralogs (3): DPY19L4 (ENSG00000156162), DPY19L2 (ENSG00000177990), DPY19L3 (ENSG00000178904)

Protein

Protein identifiers

Protein C-mannosyl-transferase DPY19L1Q2PZI1 (reviewed: Q2PZI1)

Alternative names: Dpy-19-like protein 1, Protein dpy-19 homolog 1

All UniProt accessions (8): Q2PZI1, A0A1B0GW05, A0A8I5KPK9, A0A8I5KSD1, A0A8I5KUQ5, A0A8J9BZN9, H7C1I8, H7C3M5

UniProt curated annotations — full annotation on UniProt →

Function. C-mannosyltransferase that mediates the C-mannosylation tryptophan residues on target proteins. The reaction occurs on the luminal side of the endoplasmic reticulum and involves the transfer of a mannose unit from a dolichylphosphate mannose (Dol-P-Man) donor to an acceptor protein containing a WxxW consensus sequence. C-mannosylates the first two tryptophans in the WxxWxxWxxC motif in thrombospondin (TSP) type-1 of UNC5A. Regulates neurite extension during development.

Subcellular location. Endoplasmic reticulum membrane.

Tissue specificity. Widely expressed.

Pathway. Protein modification; protein glycosylation.

Similarity. Belongs to the dpy-19 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q2PZI1-11yes
Q2PZI1-22

RefSeq proteins (2): NP_001353602, NP_056098 (=MANE)

Domains & families (InterPro)

IDNameType
IPR018732Dpy-19/Dpy-19-likeFamily
IPR047463Dpy19L1Family

Pfam: PF10034

Catalyzed reactions (Rhea), 1 shown:

  • L-tryptophyl-[protein] + a di-trans,poly-cis-dolichyl beta-D-mannosyl phosphate = C-alpha-D-mannosyl-L-tryptophyl-[protein] + a di-trans,poly-cis-dolichyl phosphate + H(+) (RHEA:77219)

UniProt features (15 total): transmembrane region 11, chain 1, region of interest 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q2PZI1-F188.510.65

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 207 (showing top): HORIUCHI_WTAP_TARGETS_DN, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, YAGI_AML_WITH_INV_16_TRANSLOCATION, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4, CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN, KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP, BILD_E2F3_ONCOGENIC_SIGNATURE, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, SENESE_HDAC1_TARGETS_UP, CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN, GRADE_COLON_AND_RECTAL_CANCER_UP, YAGI_AML_WITH_11Q23_REARRANGED, SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP

GO Biological Process (2): obsolete protein glycosylation (GO:0006486), protein C-linked glycosylation (GO:0018103)

GO Molecular Function (3): mannosyltransferase activity (GO:0000030), transferase activity (GO:0016740), glycosyltransferase activity (GO:0016757)

GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), endoplasmic reticulum (GO:0005783)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
glycoprotein biosynthetic process1
hexosyltransferase activity1
catalytic activity1
transferase activity1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
cellular anatomical structure1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

642 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DPY19L1EFCAB11Q9BUY7589
DPY19L1TSR3Q9UJK0540
DPY19L1NPSR1Q6W5P4503
DPY19L1MANBALQ9NQG1490
DPY19L1TSR1Q2NL82462
DPY19L1TSR2Q969E8460
DPY19L1OR5I1Q13606448
DPY19L1UNC5AQ6ZN44446
DPY19L1FAM24AA6NFZ4431
DPY19L1ADAMTSL1Q8N6G6427
DPY19L1CCDC152Q4G0S7397
DPY19L1SYNDIG1Q9H7V2379
DPY19L1NT5DC1Q5TFE4370
DPY19L1ZNF616Q08AN1360
DPY19L1STT3AP46977355

IntAct

105 interactions, top by confidence:

ABTypeScore
LDLRAD4NEDD4psi-mi:“MI:0914”(association)0.690
BTN3A3BTN3A1psi-mi:“MI:0914”(association)0.560
SEMA7ASGPL1psi-mi:“MI:0914”(association)0.530
APLNRMETTL15psi-mi:“MI:0914”(association)0.530
CDRT15CDRT15L2psi-mi:“MI:0914”(association)0.530
SCN3BABCC5psi-mi:“MI:0914”(association)0.530
TNFRSF8DAPK3psi-mi:“MI:0914”(association)0.530
TCTN2TPST2psi-mi:“MI:0914”(association)0.530
THBS2AP1G2psi-mi:“MI:0914”(association)0.530
SCNN1DABHD16Apsi-mi:“MI:0914”(association)0.530
UBXN8psi-mi:“MI:0914”(association)0.530
SLC22A9GPR89Apsi-mi:“MI:0914”(association)0.530
LDLRAD4WWP2psi-mi:“MI:0914”(association)0.530
PBXIP1GOLIM4psi-mi:“MI:0914”(association)0.530
HEATR3SLC27A2psi-mi:“MI:0914”(association)0.530
CD70METTL15psi-mi:“MI:0914”(association)0.530
TMEM184ASLC33A1psi-mi:“MI:0914”(association)0.530
PBXIP1KCNN4psi-mi:“MI:0914”(association)0.530
ANKRD22ESYT2psi-mi:“MI:0914”(association)0.530

BioGRID (115): DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Proximity Label-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS)

ESM2 similar proteins: A0A078H868, A0AAS4, A0JP80, A6X919, D4AD75, O70536, O77760, O77761, P23913, P35610, P53439, P56079, Q14739, Q20696, Q20735, Q28677, Q2PZI1, Q4JM44, Q4R763, Q5R7H4, Q5RK27, Q60457, Q61263, Q63632, Q63633, Q657W3, Q6AX73, Q6Z0E2, Q7T3T4, Q7TSX5, Q86VZ5, Q8IWX5, Q8NHU3, Q8VCQ6, Q91V14, Q924N4, Q965Q4, Q9D4B1, Q9FJB4, Q9H2X9

Diamond homologs: A6X919, A8Y3M2, D4AD75, P0CW70, P34413, Q2PZI1, Q5RCJ4, Q6NUT2, Q6NXN4, Q6ZN68, Q6ZPD9, Q71B07, A2AJQ3, Q5R8N9, Q7Z388, Q9VWR8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

106 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance78
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
3062981GRCh37/hg19 7p14.3-14.1(chr7:33478398-39686397)x1Likely pathogenic

SpliceAI

3286 predictions. Top by Δscore:

VariantEffectΔscore
7:34931725:CAGGC:Cacceptor_gain1.0000
7:34931727:GGC:Gacceptor_gain1.0000
7:34931730:C:CCacceptor_gain1.0000
7:34931730:CTA:Cacceptor_loss1.0000
7:34946012:TGAA:Tdonor_gain1.0000
7:34954696:A:ACdonor_gain1.0000
7:34954697:C:CCdonor_gain1.0000
7:34954697:CGT:Cdonor_gain1.0000
7:34989937:TGCCA:Tacceptor_gain1.0000
7:34989939:CCA:Cacceptor_gain1.0000
7:34989940:CA:Cacceptor_gain1.0000
7:34989940:CAC:Cacceptor_gain1.0000
7:34989941:ACT:Aacceptor_loss1.0000
7:34989942:C:CAacceptor_loss1.0000
7:34989942:C:CCacceptor_gain1.0000
7:35011325:CTTA:Cdonor_loss1.0000
7:35011326:TTAC:Tdonor_loss1.0000
7:35011327:TA:Tdonor_loss1.0000
7:35011328:A:ACdonor_gain1.0000
7:35011328:AC:Adonor_gain1.0000
7:35011328:ACCTT:Adonor_gain1.0000
7:35011329:C:CCdonor_gain1.0000
7:35011329:CC:Cdonor_gain1.0000
7:35011329:CCT:Cdonor_gain1.0000
7:35011329:CCTT:Cdonor_gain1.0000
7:35011329:CCTTC:Cdonor_gain1.0000
7:35011446:ATTAC:Aacceptor_gain1.0000
7:35011447:TTAC:Tacceptor_gain1.0000
7:35011448:TAC:Tacceptor_gain1.0000
7:35011448:TACC:Tacceptor_loss1.0000

AlphaMissense

4867 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:34941826:C:GR470T1.000
7:34949815:A:CF395L1.000
7:34949815:A:TF395L1.000
7:34949817:A:GF395L1.000
7:34949828:C:TC391Y1.000
7:34969465:A:GW255R1.000
7:34969465:A:TW255R1.000
7:34973567:G:CS214R1.000
7:34973567:G:TS214R1.000
7:34973569:T:GS214R1.000
7:34931661:C:GC647S0.999
7:34931662:A:GC647R0.999
7:34931662:A:TC647S0.999
7:34931721:C:GC627S0.999
7:34931722:A:TC627S0.999
7:34938119:T:AR582S0.999
7:34938119:T:GR582S0.999
7:34939276:C:GR582T0.999
7:34939291:T:AE577V0.999
7:34939300:G:TP574Q0.999
7:34939303:T:CH573R0.999
7:34939305:A:CN572K0.999
7:34939305:A:TN572K0.999
7:34939330:A:GL564P0.999
7:34939363:G:TA553E0.999
7:34940185:A:GL538P0.999
7:34940208:G:CF530L0.999
7:34940208:G:TF530L0.999
7:34940210:A:GF530L0.999
7:34941819:T:AK472N0.999

dbSNP variants (sampled 300 via entrez): RS1000018393 (7:35019821 T>C), RS1000069848 (7:34940565 C>T), RS1000070745 (7:35019527 A>G), RS1000085979 (7:35025639 T>C), RS1000106047 (7:35002709 G>T), RS1000166094 (7:34946278 C>T), RS1000256107 (7:34992403 TGA>T), RS1000362887 (7:34934279 T>A), RS1000399141 (7:34951935 C>T), RS1000508396 (7:34998310 GGGA>G), RS1000536185 (7:34980691 T>G), RS1000540151 (7:35037248 G>C), RS1000655144 (7:34964352 C>T), RS1000671388 (7:35009899 T>C), RS1000671968 (7:34945860 A>T)

Disease associations

OMIM: gene MIM:613892 | disease phenotypes: MIM:109730

GenCC curated gene-disease

Mondo (1): aortic valve disease 1 (MONDO:0024523)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST003262_389Post bronchodilator FEV14.000000e-06
GCST003262_390Post bronchodilator FEV15.000000e-06
GCST006098_6Vigorous physical activity6.000000e-10
GCST006857_1Leisure-time exercise behaviour2.000000e-09
GCST010136_11Fruit consumption1.000000e-08

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004314forced expiratory volume
EFO:0008002physical activity measurement
EFO:0000483exercise
EFO:0008111diet measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

37 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression, affects expression, decreases methylation6
trichostatin Aincreases expression, affects cotreatment2
Vorinostataffects cotreatment, increases expression2
Cisplatindecreases expression, increases expression2
aristolochic acid Idecreases expression1
bisphenol Fincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aaffects cotreatment, increases methylation1
butyraldehydedecreases expression1
ochratoxin Aincreases expression1
di-n-butylphosphoric acidaffects expression1
pentabromodiphenyl etherdecreases expression1
CGP 52608increases reaction, affects binding1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment, increases expression1
bisphenol Bincreases expression1
abrinedecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
dorsomorphindecreases expression, affects cotreatment, increases expression1
jinfukangdecreases expression1
bisphenol AFincreases expression1
Sunitinibincreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Bilirubindecreases expression1
Cadmiumincreases expression, increases abundance1
Calcitriolincreases expression1
Coumestrolincreases expression1
Fluorouracilaffects response to substance1
Formaldehydedecreases expression1
Ivermectindecreases expression1
Nickelincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): aortic valve disease 1